SJ

Sandip Jijaba Nikam

Active Director Director DIN 10638678
DIN 10638678 First appointment Jan 2025 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sandip Jijaba Nikam

Data last updated:

Sandip Jijaba Nikam is a Director at Three Xd Pharma Private Limited (since 2025) and Director at Genbiosis Bioresearch Private Limited (since 2025). The companies operate in Business Services.

DIN 10638678
Primary Designation Director
Industry Business Services
First Appointment 13 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Three Xd Pharma Private Limited U72100PN2025PTC240563
Director10 Apr 20252025Active
Director13 Jan 20252025Active

Directorship timeline

Open interactive timeline →
Three Xd Pharma Private Limited
Genbiosis Bioresearch Private Limited
Premium access

Shareholding and investment profile for Sandip Jijaba Nikam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandip Jijaba Nikam

Sandip Jijaba Nikam currently holds 2 directorships: Three Xd Pharma Private Limited (Director, since 10 Apr 2025); Genbiosis Bioresearch Private Limited (Director, since 13 Jan 2025).

Sandip Jijaba Nikam was first appointed on 13 Jan 2025 as Director at Genbiosis Bioresearch Private Limited.

The current boards of Sandip Jijaba Nikam's companies include Prashant Pandurang Mohite (Three Xd Pharma Private Limited), Tazeen Sadique Almelkar (Genbiosis Bioresearch Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available